These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22387224)
1. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis. Kim HS; Kim DK; Kim AR; Mun SH; Lee SK; Kim JH; Kim YM; Choi WS Cell Signal; 2012 Jun; 24(6):1306-14. PubMed ID: 22387224 [TBL] [Abstract][Full Text] [Related]
2. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135 [TBL] [Abstract][Full Text] [Related]
3. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. Cai X; Xing J; Long CL; Peng Q; Humphrey MB J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106 [TBL] [Abstract][Full Text] [Related]
4. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868 [TBL] [Abstract][Full Text] [Related]
5. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. Humphrey MB; Daws MR; Spusta SC; Niemi EC; Torchia JA; Lanier LL; Seaman WE; Nakamura MC J Bone Miner Res; 2006 Feb; 21(2):237-45. PubMed ID: 16418779 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185 [TBL] [Abstract][Full Text] [Related]
7. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages. Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094 [TBL] [Abstract][Full Text] [Related]
8. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. Mao D; Epple H; Uthgenannt B; Novack DV; Faccio R J Clin Invest; 2006 Nov; 116(11):2869-79. PubMed ID: 17053833 [TBL] [Abstract][Full Text] [Related]
9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
10. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790 [TBL] [Abstract][Full Text] [Related]
11. RANKing intracellular signaling in osteoclasts. Feng X IUBMB Life; 2005 Jun; 57(6):389-95. PubMed ID: 16012047 [TBL] [Abstract][Full Text] [Related]
12. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696 [TBL] [Abstract][Full Text] [Related]
13. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. Wu Y; Torchia J; Yao W; Lane NE; Lanier LL; Nakamura MC; Humphrey MB PLoS One; 2007 Jul; 2(7):e586. PubMed ID: 17611621 [TBL] [Abstract][Full Text] [Related]
14. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway. Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169 [TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression. Kwak HB; Lee BK; Oh J; Yeon JT; Choi SW; Cho HJ; Lee MS; Kim JJ; Bae JM; Kim SH; Kim HS Bone; 2010 Mar; 46(3):724-31. PubMed ID: 19900598 [TBL] [Abstract][Full Text] [Related]
17. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction. Kim K; Kim JH; Youn BU; Jin HM; Kim N J Immunol; 2010 Dec; 185(12):7460-6. PubMed ID: 21068407 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
19. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. Hie M; Tsukamoto I J Nutr Biochem; 2011 Feb; 22(2):164-71. PubMed ID: 20444587 [TBL] [Abstract][Full Text] [Related]
20. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption. Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]